Balanced news tone
News Sentiment
POLB sentiment intelligence
Poolbeg Pharma PLC news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
54
Balanced news tone
15 relevant articles
News tone and price action are not far from neutral.
95/100 classification confidence.
directly relevant articles
high-authority source matches
+2.2% over one week, -9.1% over four weeks, trend active, and near fair-value range.
Poolbeg Pharma Raises £3.5m as Cathal Friel Invests £250,000
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
95/100 classification
One-week reaction
2.2%
Price confirming higher
Trend fit
Trend active
-9.1% over four weeks
Fair value
3.2%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
2
Neutral
13
Negative
0
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Share Talk
Direct company coverage
Poolbeg Pharma Raises £3.5m as Cathal Friel Invests £250,000
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 14 Jul 2026 09:03
- Source
- Share Talk
Market source
Direct company coverage
Poolbeg Pharma Secures £3.5m to Advance Cancer and Obesity Programmes (POLB)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 07:15
- Source
- Market source
TradingView
Direct company coverage
REG - Poolbeg Pharma PLC - Placing to raise £3.5 million
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 14 Jul 2026 06:00
- Source
- TradingView
simplywall.st
Direct company coverage
Discover UK Penny Stocks: Poolbeg Pharma And Two More Top Picks
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 13:12
- Source
- simplywall.st
Proactive Investors
Direct company coverage
Poolbeg's European patent win bolsters partnering case before summer trial data, says Cavendish
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2026 07:00
- Source
- Proactive Investors
Investing.com Nigeria
Direct company coverage
Poolbeg Pharma receives European patent for POLB 001 in CRS By Investing.com
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2026 07:00
- Source
- Investing.com Nigeria
Share Talk
Direct company coverage
Poolbeg Pharma PLC (AIM: POLB) Preclinical data posters presented at EHA Congress
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2026 07:00
- Source
- Share Talk
Investing.com UK
Direct company coverage
Poolbeg Pharma shareholders approve AGM resolutions By Investing.com
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jun 2026 07:00
- Source
- Investing.com UK
Share Talk
Direct company coverage
Poolbeg Pharma (AIM: POLB) Pre-IND Meeting with the FDA for POLB 001
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 May 2026 07:00
- Source
- Share Talk
Yahoo! Finance Canada
Direct company coverage
Poolbeg eyes transformative summer with POLB 001 data in prospect
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Apr 2026 07:00
- Source
- Yahoo! Finance Canada
Proactive Investors
Direct company coverage
Poolbeg Pharma advances POLB 001 into UK trial - ICYMI
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Apr 2026 07:00
- Source
- Proactive Investors
Share Talk
Direct company coverage
Why 2026 could be a defining year for Poolbeg Pharma
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Apr 2026 07:00
- Source
- Share Talk
Share Talk
Direct company coverage
Poolbeg Pharma (AIM: POLB) Significant milestone for Poolbeg’s IP portfolio
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 31 Mar 2026 07:00
- Source
- Share Talk
Market source
Direct company coverage
Poolbeg Pharma shares rise 10% as Australian patent grant bolsters POLB 001 commercial appeal
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 31 Mar 2026 07:00
- Source
- Market source
GlobeNewswire
Direct company coverage
Poolbeg Pharma plc (“Poolbeg” or the “Company”) Combination of Poolbeg and HOOKIPA Pharma Inc.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jan 2025 08:00
- Source
- GlobeNewswire